Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma

Adoptive transfer of chimeric antigen receptor-transduced T cells is a promising strategy for cancer immunotherapy. The CD38 molecule, with its high expression on multiple myeloma cells, appears a suitable target for antibody therapy. Prompted by this, we used three different CD38 antibody sequences...

Cijeli opis

Bibliografski detalji

Glavni autori:	Esther Drent, Richard W.J. Groen, Willy A. Noort, Maria Themeli, Jeroen J. Lammerts van Bueren, Paul W.H.I. Parren, Jürgen Kuball, Zsolt Sebestyen, Huipin Yuan, Joost de Bruijn, Niels W.C.J. van de Donk, Anton C.M. Martens, Henk M. Lokhorst, Tuna Mutis
Format:	Artigo
Jezik:	Inglês
Izdano:	Ferrata Storti Foundation 2016-05-01
Serija:	Haematologica
Online pristup:	https://haematologica.org/article/view/7710
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!